Anum Saeed is a Cardiology physician affiliated with University of Pittsburgh. OpenAlex indexes 171 publications with 2,197 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Lothrop St
Pittsburgh, PA 152132536
Telephone
412-647-3429Provider last certified this registry record 22 Feb 2022.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- NOVARTIS PHARMACEUTICALS CORPORATIONProgram year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
96.4%Statin30.2%Rosuvastatin Calcium58%Atorvastatin Calcium42%Part D<11 patientsBeta blocker16.5%Carvedilol60%Metoprolol Succinate40%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
3.6%H2 blocker3.6%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Mid-life Inflammatory Lipid Metabolites and Atherosclerosis Burden as Modulators of Late-life Alzheimer's Disease Biomarkers
University of Pittsburgh at Pittsburgh
FY2026$804,523R01AG093987
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Journal of the American College of Cardiology
2026 - Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer’s disease
The Journal of Prevention of Alzheimer s Disease
2025 - Demographics of lipoprotein(a) and stroke: The UK biobank
American Journal of Preventive Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Udai Kammula, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”